MDR1 C3435T 基因多态性对环孢素体内代谢影响的荟萃分析

姜志平, 王一任, 徐萍, 刘荣荣, 赵谢兰, 陈方平 - 中南药学, 2008 - cqvip.com
目的过荟萃分析进一步观察MDR1 3435T 基因多态性对于环孢素体内代谢的影响.
方法过Pubmed 搜索C3435T 基因多态性对于环孢素体内代谢影响的相关文献, 提取AUC0-4 …

Influence of the G2677T/C3435T haplotype of MDR1 on P-glycoprotein trafficking and ibutilide-induced block of HERG

BF McBride, T Yang, DM Roden - The pharmacogenomics journal, 2009 - nature.com
The drug efflux pump P-glycoprotein possesses two common and often linked
polymorphisms that result in variable drug action. G2677T results in A893S, whereas …

CYP3A activity based on plasma 4β-hydroxycholesterol during the early postpartum period has an effect on the plasma disposition of amlodipine

T Naito, N Kubono, T Ishida, S Deguchi… - Drug Metabolism and …, 2015 - Elsevier
This study aimed to evaluate plasma 4β-hydroxycholesterol as an endogenous marker of
CYP3A4/5 activity in early postpartum women and its impact on the plasma disposition of …

P-gp 与癫 耐药相关性研究进展

顾浩, 张庆 - 中国实用神经疾病杂志, 2011 - cqvip.com
P-gp 是由ABCB1 基因编码的能量依赖性跨膜外向转运蛋白, 在灶组织内的表达明显增加,
影响AEDs 通过血脑屏障, 降低灶组织内AEDs 浓度. 给予P-gp 抑制剂, 不仅可以提高耐药细胞内 …

[HTML][HTML] Pharmacogenomics-based individualized treatment of hypertension in preterm infants: A case report and review of the literature

LF Tang, A Xu, K Liu - World Journal of Clinical Cases, 2023 - ncbi.nlm.nih.gov
Pharmacogenomics-based individualized treatment of hypertension in preterm infants: A case
report and review of the literature - PMC Back to Top Skip to main content NIH NLM Logo …

多药耐药基因1 C3435T 基因多态性对环孢素A 药物动力学影响的Meta 分析

李海菊, 平卫伟, 宋丽华, 郭春花, 郑王巧 - 中国组织工程研究, 2012 - cjter.com
背景: 多药耐药基因1 C3435T 基因多态性影响着P-糖蛋白的功能和表达, 从而影响环孢素A
血药浓度, 产生个体差异. 目前多药耐药基因1 C3435T 基因多态性对环孢素A …

Pharmacogenomics in Papua New Guineans: unique profiles and implications for enhancing drug efficacy while improving drug safety

JD Tucci, PP Pumuye, NA Helsby… - Pharmacogenetics …, 2018 - journals.lww.com
Abstract Papua New Guinea (PNG) can be roughly divided into highland, coastal and island
peoples with significant mitochondrial DNA differentiation reflecting early and recent distinct …

Influence of ABCB1 gene polymorphisms on the pharmacokinetics of verapamil among healthy Chinese Han ethnic subjects

LM Zhao, XJ He, F Qiu, YX Sun… - British journal of clinical …, 2009 - Wiley Online Library
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT• The pharmacokinetics of verapamil
have been assessed in a number of studies.• As a substrate of P‐glycoprotein (P‐gp) …

[HTML][HTML] Variantes del gen ABCB1 como factores de riesgo y factores moduladores de la edad de inicio en pacientes mexicanos con enfermedad desmielinizante

JLG Camacho, TC Vázquez, JJF Rivera, AO Morales… - Neurología, 2023 - Elsevier
Introducción Las variantes C1236T, G2677T/A y C3435T del gen ABCB1 alteran la función
de la glicoproteína P y el transporte de sustancias endógenas y exógenas en la barrera …

药物基因组学在高血压药物治疗中的临床应用前景

袁洪, 蔡菁菁, 黄志军 - 心血管病学进展, 2011 - cqvip.com
高血压病及其相关的心血管疾病已成为导致死亡的首要原因之一; 但全球药物降压达标率仍较低
, 其原因之一与个体间药物疗效差异较大相关, 而药物的个体反应差异又很大程度与遗传背景 …